Cargando…
Pharmacogenomics applied to recombinant human growth hormone responses in children with short stature
We present current knowledge concerning the pharmacogenomics of growth hormone therapy in children with short stature. We consider the evidence now emerging for the polygenic nature of response to recombinant human growth hormone (r-hGH). These data are related predominantly to the use of transcript...
Autores principales: | Stevens, Adam, Perchard, Reena, Garner, Terence, Clayton, Peter, Murray, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979669/ https://www.ncbi.nlm.nih.gov/pubmed/33712998 http://dx.doi.org/10.1007/s11154-021-09637-1 |
Ejemplares similares
-
Novel Mutations and Genes That Impact on Growth in Short Stature of Undefined Aetiology: The EPIGROW Study
por: Perchard, Reena, et al.
Publicado: (2020) -
Antenatal Markers Related to Fetal Growth Restriction Can Predict Childhood Systolic Blood Pressure
por: Perchard, Reena, et al.
Publicado: (2021) -
The Rationale for Growth Hormone Therapy in Children with Short Stature
por: Deodati, Annalisa, et al.
Publicado: (2017) -
Growth hormone therapy response in children with short stature
por: Gad, Amira Ahmed, et al.
Publicado: (2023) -
Significance of recombinant human growth hormone therapy in promoting growth and development of children with idiopathic short stature
por: Han, Wenbiao, et al.
Publicado: (2022)